MOTS-c is involved in multiple pathophysiological processes, i.e., improving insulin sensitivity by modulating glucose and fatty acid metabolism, transmitting signals from the mitochondria to the nucleus, ameliorating skeletal muscle atrophy, and increasing physical activity 28, 30, 33. This evidence concerns the gene INS and muscular atrophy.